hiv permissive cell line molt (ATCC)


Structured Review
Hiv Permissive Cell Line Molt, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hiv permissive cell line molt/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
molt 3 (ATCC)


Structured Review
Molt 3, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 3/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
molt (ATCC)


Structured Review

Molt, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Two-photon fluorescence lifetime imaging microscopy of NADH metabolism in HIV-1 infected cells and tissues"
Article Title: Two-photon fluorescence lifetime imaging microscopy of NADH metabolism in HIV-1 infected cells and tissues
Journal: Frontiers in Immunology
doi: 10.3389/fimmu.2023.1213180

Figure Legend Snippet: Correlating changes in NADH and eGFP expressing HIV-1 infection. 2p-FLIM imaging of eGFP and NADH with MOLT-4/CCR5 cells upon infection with HIV-1 eGFP virions. Differences in eGFP fluorescence intensity (A, B) , NADH fluorescence intensity (C, D) , average FLT of NADH (E, F) , and bound NADH FLT (G, H) for MOLT-4/CCR5 cells infected with virions compared to MOLT-4/CCR5 control. Close-up views of infected cells are shown in the panels adjacent to (B, D, F, H). Intensity histograms from corresponding images from cells with eGFP (I) and NADH (J) are shown. (K) shows the correlation plot between eGFP and NADH from individual cells. (L) shows the intensity decay of NADH from HIV-1 infected cells. The dots represent the experimental data and solid line is the bi-exponential fit to the intensity decay (see methods). Average FLT and bound form of NADH FLTs are quantified in bar graphs (M, N) . All experiments were repeated, with the average values shown. Error bars indicate standard deviations. Two-tailed test was performed for statistical analysis in panels (M) and (N) , P values; * <0.05, ** <0.01.
Techniques Used: Expressing, Infection, Imaging, Fluorescence, Two Tailed Test
molt 4 t cells (ATCC)


Structured Review
Molt 4 T Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 4 t cells/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
molt 4 (ATCC)


Structured Review
Molt 4, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 4/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
molt 4 (ATCC)


Structured Review
Molt 4, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 4/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
molt 4 (ATCC)


Structured Review
Molt 4, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 4/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
molt 4 (ATCC)


Structured Review

Molt 4, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 4/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development"
Article Title: Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development
Journal: Cell
doi: 10.1016/j.cell.2020.10.038

Figure Legend Snippet: (A) Mode of action of targeted protein degraders. (B) Experimental approach taken in this study. (C) Features of the profiled degrader library. Chemical structures reported in Table S1. (D) Kinome tree presenting protein kinases that were significantly downregulated by at least one degrader. Image created using KinMap, illustration reproduced courtesy of Cell Signaling Technology, Inc. (www.cellsignal.com). (E) Proportion of the human protein kinome detected and degraded by proteomics in at least one experiment. Data reported in Table S1, 4. (F) Comparison of degraded kinase targets reported in the literature and in this study. Literature searching was performed in PubMed, using search terms ‘kinase PROTAC’ and ‘kinase degrader’. Data reported in Table S5. (G) The number of independent compound treatments for which degradation was observed for each kinase. Inset, the top 20 most frequently degraded kinases. (H) Comparison of kinase degradability score with PubMed Count and PDB count. (I) Proportion of understudied kinases, lipid kinases and pseudokinases detected and degraded by proteomics in at least one experiment in this study. Data reported in Tables S4. (J) Scatterplot displaying relative fold change in protein abundance following treatment of MOLT-4 cells with 1 μM DD-03–156 for 5 h. Inset, chemical structure of DD-03-156. Data are from n = 1 biologically independent treatment samples. The associated dataset is provided in Table S3-4.
Techniques Used:

Figure Legend Snippet: (A) Heatmap comparing relative fold change in protein abundance in response to treatment with indicated degrader (see Table S1 for treatment details and Table S3 for data). Inset, chemical structure of degrader DB-3-291. (B) Scatterplot displaying relative fold change in protein abundance following treatment of MOLT-4 cells with 1 μM DB-3-291 for 5 h. (C) Kinome tree representing the kinase degradability (DK) score calculated for each of the protein kinases degraded in this study. Data reported in Table S8. Image created using KinMap, illustration reproduced courtesy of Cell Signaling Technology, Inc. (www.cellsignal.com). (D) Strategy for conversion of Alisertib into selective AURKA degrader dAURK-4. (E) Scatterplot depicting relative fold change in protein abundance following treatment of MOLT-4 cells with 1 μM dAURK-4 for 5 h. Data in B, E are from n = 1 biologically independent treatment samples. Associated dataset is provided in Table S3. (F) Immunoblot analysis of MM.1S cells treated with the indicated concentration of dAURK-4 for 4 or 24 h. Data in F are representative of n = 2 independent experiments. (G) DMSO-normalized antiproliferation of MM.1S cells treated with Alisertib or dAURK-4. Data are presented as mean ± s.d. of n = 3 biologically independent samples and are representative of n = 2 independent experiments.
Techniques Used: Western Blot, Concentration Assay

Figure Legend Snippet: (A) Left. Scatterplot depicts relative fold change in protein abundance following treatment of HEK293T cells (See Fig. 3A). Right. Rank order plot showing the ranked relative abundance ratios of enriched proteins in FLAG-CRBN AP-MS experiments from HEK293T cells (see Fig. 3C). Data in scatterplots are from n = 2 biologically independent treatment samples. Data in rank order plots are from n = 3 biologically independent treatment samples. Associated datasets are provided in Tables S3, 7, 6. (B) Bar chart depicting the proportion of targets complexed and degraded by the indicated compounds. (C) Venn diagrams showing number of unique and overlapping kinase hits found for each compound in MOLT-4 (blue), KELLY (orange) and HEK293T (gray) cells. (D) Kinome wide comparison of the degradation frequency and the relative protein abundance in MOLT-4 cells. (E) Bar plot showing the average relative expression the indicated proteins (left) and number of kinases degraded by the indicated degraders (right) in MOLT-4, KELLY and HEK293T cells. Average abundance measurements were derived from n = 2 independent biological samples. Associated datasets are provided in Tables S2. (F) Correlation of kinase degradability score and reported protein half-life in listed cell types.
Techniques Used: Expressing, Derivative Assay

Figure Legend Snippet: (A) Chemical structures of the compounds evaluated. (B) Intracellular ligase engagement assay. Data are represented as means ± s.d of n = 3 biologically independent replicates. (C, D) Heatmap showing log2 FC of (C) kinases, (D) known IMiD targets determined to be hits (FC >1.25 and P-value <0.01) following a 5 h treatment of MOLT-4 cells with 0.1 μM of the indicated compounds. (E) Split bar plot showing the number of CRBN-recruiting degraders found to hit at least one known IMiD off-target compared to the number that do not hit IMiD off-targets. CRBN-recruiting degraders are categorized according their linker attachment chemistry. Associated dataset is provided in Table S10.
Techniques Used:

Figure Legend Snippet: (A) Scatterplots depicting the fold change in relative abundance following a 5 h treatment of MOLT-4 cells with 1 μM of the indicated compounds with (blue) and without (orange) co-treatment with 5 μM of p97 inhibitor CB-5083. Relative expression data are derived from n = 2 biologically independent treatment. Datasets are provided in Table S3. (B) Bar chart comparing the relative protein abundance of the top 5 degraded kinases from each of the indicated treatments in A. Bars indicate relative protein expression in response to inhibition of p97 with 5 μM of CB-5083, over a time course experiment in MOLT-4 cells. Relative expression data are represented as mean ± s.d. of from n = 2 biologically independent treatment. (C) Chemical structures of GNF7-based kinase degraders utilizing either a CRBN, VHL or IAP binding moiety. (D) As in A but for compounds indicated in C. (A-D) Datasets are provided in Table S3.
Techniques Used: Expressing, Derivative Assay, Inhibition, Binding Assay
molt 4 ccr5 (ATCC)


Structured Review

Molt 4 Ccr5, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 4 ccr5/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "Monocyte-derived macrophages contain persistent latent HIV reservoirs"
Article Title: Monocyte-derived macrophages contain persistent latent HIV reservoirs
Journal: Nature Microbiology
doi: 10.1038/s41564-023-01349-3

Figure Legend Snippet: a , To determine the appropriate expander cell line, one viremic vPWH was activated with PMA in the context of MT-4, Molt-4-CCR5, CEMx174 and media only, dotted line indicates limit of detection (LOD). b , To determine the best activation condition, 7 participants ( n = 7, 4 vPWH and 3 virally suppressed vsPWH) were activated with PMA, IL-4, TNF𝛼 and media with and without MT-4 expander cells; mean ± s.d. c , To determine whether macrophages derived from negatively selected monocytes could be reactivated similarly to macrophages derived from whole PBMCs, we compared 3 participants ( n = 3, 1 vPWH and 2 vsPWH) activated with PMA and co-cultured with MT-4. d – f , To determine the appropriate assay to detect T cell contamination, in the well or via phagocytosis, we assessed CD3ε and TCRβ RNA expression in CD4 T cells isolated from healthy donors (HD). d , The CD4 T cells from 3 HD were serially diluted, lysed and RNA extracted to measure TCRβ and CDε expression; mean ± s.d. TCRβ ( e ) and CDε ( f ) showed similar variability across replicates, except at the low end of the assay. g , CD4 T cells were isolated from 8 HD; 1 × 10 6 CD4s per donor were lysed and assessed for CD3ε and TCRβ expression to determine the copies of each per cell; bar indicates median value. h , Healthy MDMs were co-cultured with HIV+ CD4 T cells from two donors (CP11 and 21) with and without PMA activation to determine whether HIV+ CD4 T cells were able to transfer viral nucleic acids to MDM; n = 2. i , A schematic of the final MDM-QVOA experimental design.
Techniques Used: Activation Assay, Derivative Assay, Cell Culture, RNA Expression, Isolation, Expressing

Figure Legend Snippet: Cell lines, MT-4, CEMx174 and MOLT4-CCR5 were assessed for HIV entry receptor expression CCR5, CXCR4 and CD4. Cell were gated on singlets and then live cells, shaded histogram is unstained cells, black line marker of interest.
Techniques Used: Expressing, Marker

Figure Legend Snippet: Culture supernatants from CP11 ( A ), CP21 ( B ), CP25 ( C ), and CP36 ( D ) positive MDM and CD4 QVOA wells were used to infect MT-4 cells and viral kinetics were assessed by measuring HIV RNA in supernatant overtime.
Techniques Used:
molt 4 (ATCC)


Structured Review

Molt 4, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/molt 4/product/ATCC
Average 86 stars, based on 1 article reviews
Price from $9.99 to $1999.99
Images
1) Product Images from "IMMUNEPOTENT CRP increases intracellular calcium through ER-calcium channels, leading to ROS production and cell death in breast cancer and leukemic cell lines"
Article Title: IMMUNEPOTENT CRP increases intracellular calcium through ER-calcium channels, leading to ROS production and cell death in breast cancer and leukemic cell lines
Journal: EXCLI Journal
doi: 10.17179/excli2022-5568

Figure Legend Snippet: IMMUNEPOTENT CRP induces different regulated cell death modalities concentration and ROS-dependent manner on breast cancer and in T-ALL cell lines. A-B. Representative dot plots and quantification of cell death measured by flow cytometry using Annexin-V and PI staining in breast cancer cell lines MCF-7 (above) and 4T1 (down) (A) and in T-acute lymphoblastic leukemia cells lines CEM (above) and MOLT-4 (down) (B) treated with different concentrations of ICRP for 24 h. C. Cell death quantification of MCF-7, 4T1, CEM and MOLT-4 cell lines left alone or pretreated with a pan-caspase inhibitor QVD before ICRP CC 50 treatment (24 h). D. Cell death quantification in MCF-7, 4T1, CEM and MOLT-4 cell lines left alone or pretreated with the antioxidant NAC before ICRP CC 50 treatment (24 h). The means (± SD) of triplicates of at least three independent experiments were graphed.
Techniques Used: Concentration Assay, Flow Cytometry, Staining

Figure Legend Snippet: IMMUNEPOTENT-CRP induces prosurvival autophagosome formation on breast cancer and in T-ALL cell lines. A. Representative histograms (left) and quantification (right) of autophagosome formation measured by flow cytometry using Cyto-ID staining in breast cancer MCF-7 and 4T1 cells, and leukemic CEM and MOLT-4 cell lines treated with ICRP CC 50 (24 h). B. Representative dot plots (left) of cell death analysis in MCF-7, 4T1, CEM and MOLT-4 cell lines left alone or pretreated with the autophagy inhibitor Sp-1 before ICRP treatment CC 50 (24 h) and quantification (C). The means (± SD) of triplicates of at least three independent experiments were graphed.
Techniques Used: Flow Cytometry, Staining

Figure Legend Snippet: IMMUNEPOTENT-CRP induces eIF2α phosphorylation and increases in the cytoplasmic Ca 2+ levels. A. Representative histograms and quantification of eIF2α phosphorylation measured by flow cytometry using anti-EIF2S1 monoclonal antibody in breast cancer cell lines MCF-7 and 4T1 (left), and leukemic cells lines CEM and MOLT-4 (right). B. Confocal microscopy representation of Ca 2+ cytoplasmic levels measured by Fluo-4AM staining in breast cancer cell lines MCF-7 (left) and 4T1 (right) in absence (control) or presence of ICRP CC 50 for 18 h and visualized using fluorescence microscopy (OLYMPUS X70) (40×). C. Fluorescence microscopy representation of Ca 2+ cytoplasmic levels measured trough Fluo-4AM staining in leukemic cell lines CEM (left) and MOLT-4 (right) in absence (control) or presence of ICRP CC 50 for 18 h and visualized using fluorescence microscopy (OLYMPUS IX70) (40×). D-E. Representative histograms and quantification of Ca 2+ cytoplasmic levels assessed through Fluo-4AM staining by flow cytometry in breast cancer cell lines MCF-7 and 4T1 (above) (D), and in T-ALL cell lines CEM and MOLT-4 (down) (E) treated with ICRP CC 50 for 18 h. Graphs represent the mean (± SD) of triplicates of at least three independent experiments.
Techniques Used: Flow Cytometry, Confocal Microscopy, Staining, Fluorescence, Microscopy

Figure Legend Snippet: IMMUNEPOTENT CRP induces Ca 2+ -dependent cell death in tumoral and leukemic cell lines. A. Representative dot plots and quantification of cell death measured by flow cytometry through Annexin-V and PI staining in breast cancer cell lines MCF-7 and 4T1 (above), and in T-ALL cell lines CEM and MOLT-4 (down) treated with ICRP CC 50 for 24 h in presence or absence of BAPTA. B. Representative histograms and quantification of caspase-3 cleaved by flow cytometry using FITC-DEVD-FMK staining in T-ALL cell lines CEM (left) and MOLT-4 (right) treated with ICRP CC 50 for 24 h in presence or absence of BAPTA. C-D. Quantification of loss of mitochondrial membrane potential (C) and ROS production (D) evaluated through TMRE and DCFDA staining, respectively, by flow cytometry in breast cancer cell lines MCF-7 and 4T1, and in T-ALL cell lines CEM and MOLT-4 treated with ICRP CC 50 for 24h in presence or absence of BAPTA. Graphs represent the mean (± SD) of triplicates of at least three independent experiments.
Techniques Used: Flow Cytometry, Staining

Figure Legend Snippet: IMMUNEPOTENT-CRP induces Ca 2+ -dependent cell death in breast cancer and leukemic cell lines. A. Fluorescence microscopy representation (left) and quantification (right) of Ca 2+ cytoplasmic levels measured through Fluo-4AM staining in breast cancer MCF-7 and 4T1 and leukemic cell lines CEM and MOLT-4 treated with ICRP CC 50 for 18 h and in presence or absence of 2-APB and Dantrolene, visualized using fluorescence microscopy (OLYMPUS IX70) (40×). B. Quantification of ROS production assessed by DCFDA staining by flow cytometry in breast cancer cell lines MCF-7 and 4T1, and in T-ALL cell lines CEM and MOLT-4 treated with ICRP CC 50 for 24 h in presence or absence of 2-APB and Dantrolene. C. Quantification of cell death measured by flow cytometry through Annexin-V and PI staining in breast cancer cell lines MCF-7 and 4T1 (above), and T-ALL cell lines CEM and MOLT-4 (down) treated with ICRP CC 50 for 24 h in presence or absence of 2-APB and Dantrolene. Graphs represent the mean (± SD) of triplicates of at least three independent experiments.
Techniques Used: Fluorescence, Microscopy, Staining, Flow Cytometry